Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences
  • Healthcare
Life Sciences

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences
Healthcare

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
U.S. BLOGS

Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!

LEARN MORE

U.S. INSIGHTS LIBRARY

"Browse our library of insights and thought leadership.

LEARN MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

LEARN MORE
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

LEARN MORE

Launch Excellence, the U.S. Edition: The Rewrite of the Business of Launch – Optimize

"Aligning legislative requirements, payer expectations regarding pricing and evidence, and meeting patients’ needs is now crucial for successful launches.

Learn more
MAIN/Contact Us
Contact Us/
Webinar
Cell and Gene Therapy: How Can They Be the Future of Healthcare with So Many Market Access Challenges?
calendar

September 7, 2023

Calendar
clock

11:00am - 12:00pm

GMT-04:00

Register

  • Locations
  • United States
  • Cell and Gene Therapy: How Can They Be the Future of Healthcare with So Many Market Access Challenges?
View all IQVIA events
View Now

Some of the most innovative and efficacious new products being launched are cell and gene therapies. However, healthcare systems globally are not set up to properly capture the value of these therapies given most are single-use, and have high upfront cost, uncertain durability of effect, and are not proven consistently safe.

Key objectives:

  • Review what makes cell and gene therapies unique, and why that creates market access challenges, but also opportunities
  • Discuss how innovative contracting is helping to overcome some of the global market access challenges, but new approaches may be needed for reimbursement
  • Share perspectives on what the future market access environment will be for cell and gene therapies

Speakers

Rob Glik
 VP and GM, Value & Access Strategy Consulting, IQVIA

Justin DiSanto
Principal, Value & Access Strategy Consulting, IQVIA

You may also be interested in

Institute Report
Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios
Institute Report
Protection Expiry and Journey into the Market
Infographic
Single Drug Assessments in Lung Cancer
Infographic
A lifecycle approach to the use of RWE in HTA submissions and re-submissions, a decade's experience
White Paper
Making the Move: Bringing Cell and Gene Therapy Development Programs to the United States
Publication
Pricing & Market Access Outlook 2018
Prev
Next

Related solutions

Market Access

Gain high value access and increase the profitability of your brands

Contact Us